In comparison, in Brg1-KO tumor cells, we found no difference in Pcna immunoreactivity between pRb1T821/826-positive and pRb1T821/826-negative tumor cells (45.9% vs. 49.1%, respectively, p=0.66). This evidence concerns the gene PCNA and neoplasm.